Screening for antiviral inhibitors of the HIV integrase-LEDGF/p75 interaction using the AlphaScreen luminescent proximity assay.

@article{Hou2008ScreeningFA,
  title={Screening for antiviral inhibitors of the HIV integrase-LEDGF/p75 interaction using the AlphaScreen luminescent proximity assay.},
  author={Yan Hou and Debra Mcguinness and Andrew J. Prongay and Boris Feld and Paul Ingravallo and Robert A. Ogert and Charles A. Lunn and John A. Howe},
  journal={Journal of biomolecular screening},
  year={2008},
  volume={13 5},
  pages={406-14}
}
Small-molecule inhibitors of HIV integrase (HIV IN) have emerged as a promising new class of antivirals for the treatment of HIV/AIDS. The compounds currently approved or in clinical development specifically target HIV DNA integration and were identified using strand-transfer assays targeting the HIV IN/viral DNA complex. The authors have developed a second biochemical assay for identification of HIV integrase inhibitors, targeting the interaction between HIV IN and the cellular cofactor LEDGF… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
16 Extracted Citations
28 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 16 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 28 references

First report of raltegravir (RAL, MK-0518) use after virologic rebound on elvitegravir (EVT, GS 9137) [Poster TUPEB032

  • E DeJesus, C Cohen, R Elion, R Ortiz, L Maroldo, S Franson
  • Paper presented at the 4th International AIDS…
  • 2007
1 Excerpt

Similar Papers

Loading similar papers…